Recruiting NA Respiratory Distress Syndrome

New treatment option for Respiratory Distress Syndrome

Official title Influence of Flow Rate Change on CO2 Levels During High Flow Nasal Ventilation (HFNV) in Preterm Infants.

ClinicalTrials.gov ID: NCT06622902

What this study is testing

What it's testing
Background Preterm infants often need respiratory support. HFNV is a non-invasive method with benefits over CPAP, such as reduced nasal trauma and improved feeding.
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Adults

You may be able to join if

  • Gestational age 240 to 336.
  • At least 6 hours of stabilized HFNP settings, i.e. minor changes in settings (FiO2 ≤0.10, no change in flow).
  • At least 6 hours of stabilized tcCO2, i.e. ≤5 mmHg variation.
  • At least 6 hours from surfactant administration.
  • Parental consent

You likely can't join if

  • If flow is \<3 and tcCO2 related pCO2 is\<40mmHg.
  • If Flow is ≥5 bpm and tcCO2 related pCO2 is\>60mmHg.
  • Unstable infants due to acute conditions (sepsis. IVH), or congenital malformations.

The study team makes the final eligibility decision.

Where it's taking place

  • Haifa, Israel

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, not specified. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Haifa, Israel. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.